arXiv subjects

Eva Kasanda

Publications and source records attributed to Eva Kasanda.

5 recordsLinked to original sources

arXiv2026

Development of a Proton Therapy Research Beamline with FLASH and Minibeam Capabilities at the 18 MeV Bern Medical Cyclotron

Advanced radiotherapy approaches such as FLASH irradiation and spatially fractionated radiotherapy (SFRT) show potential to improve the therapeutic ratio, yet their biological mechanisms and optimal delivery parameters remain uncertain. Progress requires accessible proton research platforms with flexible temporal and spatial dose delivery. We report on the adaptation of the Beam Transfer Line (BTL) of the Bern Medical Cyclotron (BMC) for radiobiology research with FLASH and proton minibeam capabilities. The BMC is optimized for the production of radionuclides for medical imaging, and is able to extract currents up to 150 $ \mathrm{\mu A}$. The 18 MeV proton beam was passively shaped using collimators, scattering foils, and extended drift space to generate irradiation fields. A dosimetric framework was implemented using an in-beam ionization chamber and radiochromic film with LET-dependent corrections. Beam uniformity and SFRT profiles with various grid spacings were evaluated at realistic target distances. The developed beamline enables stable delivery under controlled conditions in both conventional and FLASH regimes, spanning dose rates from 0.01 to 100 Gy/s. Dose uniformity within a 20 mm radius was below 8\%. Film measurements confirmed the need for LET-dependent corrections and indicated that quantitative dosimetry in in-vitro setups is achievable with appropriate LET corrections. The low proton energy (15.54(12) MeV extracted into air, 8.14(28) MeV delivered to cells in flask) facilitates compact SFRT implementation with well-resolved minibeams. The adapted BMC provides a flexible and accessible platform for systematic pre-clinical proton radiobiology studies under varied dose-rate and spatial delivery conditions. This supports optimization of emerging modalities such as proton FLASH and SFRT and helps bridge accelerator technology and radiobiology.

physics.med-ph↗

arXiv2026

Non-Destructive Beam Monitoring via Secondary Radiation Detection with Ce-Doped Silica Fibers

Non-destructive beam diagnostics are essential for low-energy medical cyclotrons, where even thin interceptive devices can severely degrade beam quality. We investigate an external fiber monitor (EFM) based on Ce-doped silica scintillating fibers that detects secondary radiation generated at existing beamline components of the 18 MeV Bern Medical Cyclotron beam transfer line (BTL). Three use cases were studied: (i) beam intensity monitoring around an electrically isolated, water-cooled beam dump; (ii) beam-loss monitoring around a 10 mm collimator under varying the beam focusing; and (iii) by steering a 6.5 mm $\times$ 6.5 mm beam spot on a beam dump. For case (i), the summed EFM signal exhibits a linear dependence on the current on target over nearly three orders of magnitude. In case (ii), a normalized EFM-based beam-loss proxy scales monotonically with an electrical loss proxy across several focusing settings. Furthermore, opposing-fiber signal ratios provide decoupled, monotonic sensitivity to horizontal and vertical beam displacements.

physics.ins-det↗

arXiv2025

Beam Energy Measurement using a Bayesian Approach with the Stacked Foil Method

We present a practical method to measure the energy of proton beams at a medical cyclotron using the stacked foil technique in combination with a Bayesian inference method. By measuring the $^{48}$V activity induced in a stack of irradiated titanium foils, the proton energy can be inferred without relying on direct current or charge measurements, making the method suitable even for low-vacuum environments or air-exposed setups. This technique is further extended to configurations where the beam energy is degraded to levels around 8 MeV. A Bayesian fit of the measured activity profile allows not only for a robust energy estimation but also for a consistent treatment of uncertainties and nuisance parameters. Monte Carlo simulations are employed to validate the underlying assumptions, including the impact of energy dispersion or cross-section uncertainties. Our results demonstrate that this method provides accurate beam energy measurements across several typical experimental setups used at the Bern Medical Cyclotron. Additionally, we evaluate the sensitivity of the method to the choice of nuclear cross-section data and assess how the number of foils in the stack affects the uncertainty in the inferred beam energy.

physics.acc-ph↗

arXiv2021

Intra- and Inter-Fraction Relative Range Verification in Heavy-Ion Therapy Using Filtered Interaction Vertex Imaging

Heavy-ion therapy, particularly using scanned (active) beam delivery, provides a precise and highly conformal dose distribution, with maximum dose deposition for each pencil beam at its endpoint (Bragg peak), and low entrance and exit dose. To take full advantage of this precision, robust range verification methods are required; these methods ensure that the Bragg peak is positioned correctly in the patient and the dose is delivered as prescribed. Relative range verification allows intra-fraction monitoring of Bragg peak spacing to ensure full coverage with each fraction, as well as inter-fraction monitoring to ensure all fractions are delivered consistently. To validate the proposed filtered Interaction Vertex Imaging method for relative range verification, a ${}^{16}$O beam was used to deliver 12 Bragg peak positions in a 40 mm poly-(methyl methacrylate) phantom. Secondary particles produced in the phantom were monitored using position-sensitive silicon detectors. Events recorded on these detectors, along with a measurement of the treatment beam axis, were used to reconstruct the sites of origin of these secondary particles in the phantom. The distal edge of the depth distribution of these reconstructed points was determined with logistic fits, and the translation in depth required to minimize the $\chi^2$ statistic between these fits was used to compute the range shift between any two Bragg peak positions. In all cases, the range shift was determined with sub-millimeter precision, to a standard deviation of the mean of 220(10) $\mu$m. This result validates filtered Interaction Vertex Imaging as a reliable relative range verification method, which should be capable of monitoring each energy step in each fraction of a scanned heavy-ion treatment plan.

physics.med-ph↗

arXiv2020

GEANT4 simulation of a new range verification method using delayed gamma spectroscopy of a Mo-92 marker

In this work, we propose a novel technique for in-vivo proton therapy range verification. This technique makes use of a small hadron tumour marker, $^{92}$Mo, implanted at a short known distance from the clinical treatment volume. Signals emitted from the marker during treatment can provide a direct measurement of the proton beam energy at the marker's position. Fusion-evaporation reactions between the proton beam and marker nucleus result in the emission of delayed characteristic $γ$ rays, which are detected off-beam for an improved signal-to-noise ratio. In order to determine the viability of this technique and to establish an experimental setup for future work, the Monte Carlo package GEANT4 was used in combination with ROOT to simulate a treatment scenario with the new method outlined in this work. These simulations show that analyzing the intensity of delayed $γ$ rays produced from competing reactions yields a precise measurement of the range of the proton beam relative to the marker, with sub-millimeter uncertainty.

physics.med-ph↗